Browsing: weight

Eli Lilly’s new weight-loss pill orforglipron – brand named Foundayo – has been authorised today (10 August) by the Medicines and Healthcare products Regulatory Agency (MHRA)

The British medicines regulator has approved Eli Lilly’s Foundayo pill, marking a first in Europe for weight management and type 2 diabetes treatment

A daily weight-loss pill made by the drug firm behind the Mounjaro jab has been approved for use in the UK – the first country in Europe to do so

A once-daily weight-loss pill that works in a similar way to injectable drugs such as Mounjaro has been approved for use in the UK

Eli Lilly’s Foundayo (orforglipron) has secured UK regulatory approval for weight management and type 2 diabetes, making the UK the first European country to authorise the once-daily GLP-1 tablet

A new oral approach to GLP-1 treatment helped adults with obesity or overweight lose as much as 12 percent of their body weight over 36 weeks, according to a randomized phase II clinical trial published in Nature Medicine

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

A law student’s sudden death, while studying abroad, has been linked to a popular weight loss drug

The UK has become the first country in Europe to approve a new once-a-day pill to aid weight loss and treat type 2 diabetes

The UK has made history by becoming the first European nation to approve Eli Lilly’s groundbreaking weight management pill, Foundayo, aimed at aiding those with type 2 diabetes. The British Medicines and Healthcare products Regulatory Agency (MHRA) announced its authorization on Monday